Apellis Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.29%38.060.9%$1107.43m
JNJJohnson & Johnson 0.14%148.210.7%$820.15m
MRKMerck & Co., Inc. -0.08%83.470.7%$646.78m
ABBVAbbVie, Inc. 0.42%95.081.9%$619.40m
BMYBristol-Myers Squibb Co. -0.14%63.151.0%$617.68m
AZNAstraZeneca Plc -1.08%55.201.2%$504.65m
LLYEli Lilly & Co. -0.25%150.091.1%$396.64m
NVSNovartis AG -0.84%84.650.2%$154.29m
GSKGlaxoSmithKline Plc -1.55%40.550.2%$129.26m
MISTMilestone Pharmaceuticals, Inc. -2.17%8.550.0%$117.60m
OPKOPKO Health, Inc. -1.13%4.8011.2%$113.10m
NVONovo Nordisk A/S -0.85%65.780.1%$68.42m
RGENRepligen Corp. -1.62%143.897.1%$65.57m
IMRNImmuron Ltd. 9.27%11.080.0%$54.00m
SNYSanofi -2.03%50.330.2%$53.85m

Company Profile

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.